FFX shareholders;
Contrary to the above post;
re: "(sic)... FFX is delisted and management do no need to keep the flow of information coming as would be expected of an ASX listed company ...(sic)"
Section 675 of the Corporations Act 2001
Continuous disclosure -- other disclosing entities -- reasonable person expectations;
(1) This section applies to:
(a) a listing disclosing entity;
(b) an unlisted disclosing entity
(2) If:
(a) the disclosing entity becomes aware of information that is not generally available; and
(b) a reasonable person would expect the information, if it were generally available, to have a material effect on the price or value of the securities of the entity
Note 1: Failure to comply with this subsection is an offence and Note 3: an infringement notice may be issued for an alleged contravention of this subsection
Also note from the Company's announcement:
Shareholder Update regarding delisting - 27 June 2024
"Once removed from the official list of ASX, it should be noted that the company will become an "unlisted disclosing entity" subject to the same continuous disclosure obligations in section 675 of the Corporations Act. These are similar to the continuous disclosure obligations imposed under section 674 of the Corporations Act and ASX Listing Rule 3.1."
- Forums
- ASX - By Stock
- FFX
- Letter to Company
Letter to Company, page-9
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online